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Abstract
Background: Representing species-specific proteins and protein complexes in ontologies that are both human-
and machine-readable facilitates the retrieval, analysis, and interpretation of genome-scale data sets. Although
existing protin-centric informatics resources provide the biomedical research community with well-curated
compendia of protein sequence and structure, these resources lack formal ontological representations of the
relationships among the proteins themselves. The Protein Ontology (PRO) Consortium is filling this informatics
resource gap by developing ontological representations and relationships among proteins and their variants and
modified forms. Because proteins are often functional only as members of stable protein complexes, the PRO
Consortium, in collaboration with existing protein and pathway databases, has launched a new initiative to
implement logical and consistent representation of protein complexes.
Description: We describe here how the PRO Consortium is meeting the challenge of representing species-specific
protein complexes, how protein complex representation in PRO supports annotation of protein complexes and
comparative biology, and how PRO is being integrated into existing community bioinformatics resources. The PRO
resource is accessible at http://pir.georgetown.edu/pro/.
Conclusion: PRO is a unique database resource for species-specific protein complexes. PRO facilitates robust
annotation of variations in composition and function contexts for protein complexes within and between species.
Background
Logical and semantic access to related protein forms is
critical for advancing bioinformatics approaches to
representing, modeling, and reasoning about complex
biological systems at the genomic and cellular level [1].
The Protein Ontology (PRO) Consortium develops and
maintains ontology resources for the representation of
protein forms for all organisms [2]. PRO is one of the
six inaugural ontologies that form the Open Biological
and Biomedical Ontologies (OBO) Foundry [3].
The PRO has three components informally referred to
as ProForm, ProEvo, and ProComp [4]. ProForm repre-
sents species-specific and species-independent classes of
protein isoforms, co- and post-translationally modified
forms, and variant forms. ProEvo represents evolution-
ary relatedness of proteins.P r o C o m p ,t h ef o c u so ft h i s
manuscript, represents multi-protein complexes, with an
initial (but not exclusive) emphasis on protein compo-
nents of complexes in mouse and human. ProComp,
uses the Gene Ontology [5] (GO) definition of protein
complex: “Any macromolecular complex composed of
two or more polypeptide subunits, which may or may
not be identical. Protein complexes may have other
associated non-protein prosthetic groups, such as
nucleotides, metal ions or other small molecules.”
(GO:0043234). Therefore protein complexes may, in
addition, have components that are nucleic acids, carbo-
hydrates, or lipids. Protein complexes are distinguished
from protein-protein interactions in that they are conti-
nuant entities, i.e. they endure or continue to exist
through time. Interactions, in contrast, are occurrent
entities, i.e. they occur in time through successive tem-
poral phases. The explicit representation of protein
complexes in PRO–defining each member of the com-
plex at the level of its isoform, variant, or modified
form–provides the ability to represent complex biologi-
cal knowledge as it is emerging in the experimental
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readable and accessible to algorithmic approaches.
ProComp leverages, and cross references, entries in
existing protein-centric informatics resources, including
the protein complexes that are represented in the Cellu-
lar Component branch of the Gene Ontology. In the
GO, types of protein complexes are defined in terms of
constituent macromolecule classes and the function(s)
that the complexes carry out. By agreement within the
protein informatics community, PRO represents the spe-
cies-specific classes of protein complexes, while GO, in
most instances, represents the species-independent
classes of protein complexes; within PRO, the latter are
referred to by using GO identifiers. The UniProt Knowl-
edgebase (UniProtKB) [6,7] describes protein complexes,
though not as separate accessioned entities. References
to protein records in UniProtKB are made through
entries in the ProForm sub-ontology within PRO (Figure
1). A major contribution of PRO as a protein biology
community informatics resource is that it provides a
formal ontological structure with foundation in Basic
Formal Ontology http://www.ifomis.org/bfo/to describe
types of protein complexes and gives these types unique,
permanent identifiers http://www.obofoundry.org/id-pol-
icy.shtml. PRO facilitates functional annotation of pro-
teins and protein complexes with specific cellular
contexts; it promotes compatibility with other ontology
resources; and it promotes use of software tools for rea-
soning and analysis.
Uniquely among protein biology community infor-
matics resources, PRO follows a principles-based strat-
egy for ensuring ontological adequacy (i.e. biologically
accurate, logically coherent and computationally useful).
Some of these principles flow from the PRO’sm e m b e r -
ship of the OBO (Open Biological and Biomedical
Ontologies) Foundry. The OBO Foundry requires the
use of Basic Formal Ontology http://www.ifomis.org/
bfo/ as the top-level formal ontological structure; this
ensures compliance with standard methodologies for
ensuring formal adequacy such as OntoClean [8]. The
OBO Foundry also requires the use of a standard formal
syntax (we maintain versions in both OWL and OBO,
Figure 1 Schematic showing the relationships between UniProtKB, ProForm, GO, and ProComp. Arrows between ProForm and UniProtKB
are xref, those between ProComp and ProForm are has_part, and between ProComp and Gene Ontology the arrows depict is_a relationships. In
ProForm each protein form is assigned a unique identifier and is cross-referenced to protein entries in UniProtKB. Protein isoforms and modified
forms are described in UniProtKB records, but in contrast to PRO, each protein form is not represented as a separate, uniquely accessioned entity
in UniProtKB. For example, for the alpha subunit of IDH in mouse there is a PRO entry for the protein (PR:000025358) and for each of the alpha
protein isoforms (PR:000025355 and PR:000025356). In UniProt the IDH alpha subunit and its isoforms are all represented in the same record
(UniProt: Q9D6R2). In ProComp, accessioned, species-specific protein complex entities are described using protein entries from ProForm. The
protein complexes in ProComp are cross-referenced to species-independent complex representations in the Gene Ontology (GO).
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sistency checking, but also providing an added layer of
quality assurance by requiring the two versions to satisfy
the formal principles needed for the two-way OBO-to-
OWL mapping tools to run effectively). In addition, the
OBO Foundry requires that an ontology is maintained
and regularly updated to keep pace with scientific
advances, rectify errors, and fill gaps identified by its
users. Other principles to ensure ontological adequacy
apply specifically to the PRO and to its constituent
branches, including ProComp.
The development of ProComp, in particular, relies on
high-level scientific content deriving from research on
cellular contexts, diseases and, model organisms in addi-
tion to protein biology and chemistry. This requirement
is addressed by a final OBO Foundry principle, which
requires that each ontology is maintained in such a way
as to involve the developers and users of other neigh-
boring ontologies (e.g., GO, ProForm, ProEvo, etc.) in
order to ensure consistency of scientific content. The
ongoing process of critical review by representatives of
multiple complementary disciplines is designed to guar-
antee that the ontology is developed on the basis of the
best current scientific understanding of relevant subject-
matters in each of these disciplines.
In this communication we present elements of PRO’s
current approach for representing species-specific types
of protein complex, illustrate how they are being inte-
grated with existing pathway database resources, and
describe how the ProComp effort facilitates comparative
protein biology and functional genomics.
Construction and Content
Representation of protein complexes
The Protein Ontology is authored using the OBO 1.2
format [9]. The OBO format supports algorithmic rea-
soning and is also human readable. Terms in an OBO
ontology are described by “stanzas.” Each OBO stanza
has an identifier, term name, and a textual term defini-
tion; the stanzas may also contain comments and syno-
nyms. A series of relationship declarations are used to
construct a logical definition. The declarations relate the
term to other terms within the PRO ontology as well as
to other ontologies, such as the GO (Figure 1).
The protein complex types in PRO are defined by
means of multiple part relationships to PRO-defined spe-
cies-specific protein types. The species-specific protein
types can be of isoforms or modified isoforms. Each PRO
complex stanza includes an is_a (i.e. subtype) relation-
ship to the corresponding Gene Ontology (GO) protein
complex term (Figure 1). Cross references to protein
entries in UniProtKB are not included in protein complex
stanzas. Instead they are part of the stanzas that repre-
sent the component proteins in ProForm (Figure 1).
The initial development of ProComp makes use of
examples of known protein complexes drawn from well-
established, manually-curated pathway databases: Eco-
Cyc [10], MouseCyc [11] and Reactome [12,13]. The
close collaboration of PRO with these databases ensures
that PRO allocates effort where there is demonstrated
need, and that PRO’s definitions are accessible to the
biomedical research community in the functional con-
text of cellular pathways. EcoCyc http://ecocyc.org
represents transcriptional regulation, transporters, and
biochemical pathways for Escherichia coli.M o u s e C y c
http://mousecyc.jax.org focuses on pathways involved in
biosynthesis, degradation, energy production, and detox-
ification. MouseCyc is unique among mammalian path-
way resources in that the database is connected with the
rich biological knowledge about mouse gene function
and phenotypes contained in the Mouse Genome Infor-
matics database (MGI; http://www.informatics.jax.org)
[14]. Reactome is a manually curated knowledgebase of
human biological pathways http://www.reactome.org. In
Reactome, pathways are represented as series of molecu-
lar events that transform one or more input physical
entities into one or more output entities, catalyzed or
regulated by other entities. Entities include small mole-
cules, proteins, post-translationally modified proteins,
and complexes. Current priorities for ProComp are to
create entries for all protein complexes in the contribut-
ing databases with an emphasis first on those with pub-
lished species-specific experimental evidence and those
with human disease relevance. Although ProComp is
being populated initially from a few targeted database
resources, information about protein complexes will also
be obtained from other database resources such as
IntAct [15] and the primary published literature.
Utility and Discussion
Below we describe four use cases to highlight key ele-
ments in the representation of protein complexes in
PRO and to illustrate how aspects of biological knowl-
edge and complexity are being captured in ProComp.
Use Case 1. The 3-methylcrotonyl carboxylase (MCC)
Complex: A heterodimeric complex
The MCC protein complex (E.C. 6.4.1.4) is a mitochon-
drial, biotin-dependent heterodimeric enzyme consisting
of alpha and beta subunits. The PRO stanza for the
murine MCC complex is illustrated below with key
points illustrated by bold text. The ID for this protein
complex type (PR:000025760 = http://purl.obolibrary.
org/obo/PR_000025760) is unique, permanent, and is
resolvable on the web to useful information. This class
of complex is a subclass of the class of species-nonspeci-
fic MCC protein complexes defined in the Gene Ontol-
ogy (GO:0002169) and this relationship is explicitly
represented using an is_a statement in the stanza. The
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the value of the only_in_taxon tag. The MCC complex
has two components, an alpha and beta subunit repre-
sented by the has_part relationships that assert that
each instance of the complex contains an instance of
indicated peptide. The embedded cardinality declaration
indicates the number of instances of that type of subunit
in the complex. In the case of murine MCC, the cardin-
ality declarations indicate that each complex has exactly
one of each subunit (alpha-beta). The absence of a car-
dinality declaration indicates there is at least one copy
of each subunit.
We deliberately use has_part to relate the complex to
the subunit rather than part_of to relate the subunit to
the complex. The latter protein-centric statement would
indicate that each instance of the peptide is part of
some instances of the indicated complex, which is not
necessarily the case, as the peptide could exist in a free
form or as part of other complexes. Finally, that this is a
protein complex only found in mouse is represented by
tag only_in_taxon paired with the official taxon identi-
fier. The totality of these relationship statements makes
up the logical definition for this complex type.
[Term]
id: PR:000025760
name: methylcrotonoyl-CoA carboxylase complex,
mitochondrial (mouse)
def: “A methylcrotonyl-CoA carboxylase complex,
mitochondrial, whose components are encoded in the
genome of mouse.” [PRO:CJB]
comment: Category = organism-complex. Entities of
this type are disposed to have the enzymatic activity
described by EC:6.4.1.4.
synonym: “beta-methylcrotonyl-CoA carboxylase
(mouse)” EXACT []
synonym: “MCC (mouse)” EXACT []
is_a: GO:0002169! 3-methylcrotonyl-CoA carboxy-
lase complex, mitochondrial
relationship: has_part PR:000025354 {cardinality =
“1”} ! methylcrotonoyl-CoA carboxylase subunit alpha,
mitochondrial (mouse)
relationship: has_part PR:000025357 {cardinality =
“1"} ! methylcrotonoyl-CoA carboxylase beta chain,
mitochondrial (mouse)
relationship: only_in_taxon taxon:10090 ! Mus
musculus
Use Case 2. The serine palmitoyltransferase (SPT) Complex:
Differences in prokaryotic and eukaryotic protein complex
organization
Serine palmitoyltransferase (SPT; EC 2.3.1.50) catalyzes
the key reaction in the biosynthesis of sphingolipids. In
many eukaryotic species, this enzyme is a heterodimer
consisting of two subunits, SPTLC1 and SPTLC2.
Recently, it was shown that in human cells, SPTLC1
and SPTLC2 form a complex with a third subunit,
SPTLC3, with a resulting molecular mass of 480 kDa
[16]. SPTLC1 is a common subunit to two core com-
plexes SPTLC1-SPTLC2 and SPTLC1- SPTLC3, and it
is likely that the ratio of SPTLC2 to SPTLC3 subunits
in the SPT complexes, as well as binding of some smal-
ler regulatory subunits, confers preferential activity of
SPT complexes to specific acyl-CoA substrates [17,18].
A serine palmitoyltransferase complex is also found in
gram-negative sphingolipid-containing bacteria. Unu-
sually, the outer membranes of these bacteria contain
glycosphingolipid (GSL) instead of lipopolysaccharide,
and SPT catalyzes the first step of the GSL biosynthetic
pathway in these organisms. But, as opposed to the
human SPT complex, bacterial SPT complex is homodi-
meric [19-21]. In some bacterial species the complex is
water-soluble, whereas in eukaryotes the complex is
membrane-bound. The component subunits of bacterial
and eukaryotic SPT complexes are evolutionarily-related,
and this relationship is evidenced in the ontology (Fig-
ure 2; both the bacterial and eukaryotic serine palmi-
toyltransferases trace back to the same progenitor class
of pyridoxal 5’-phosphate (PLP)-dependent alpha-oxoa-
mine synthase).
The representation of SPT complexes in PRO shown
below and illustrated in Figure 2 highlights the differences
in composition among human complexes and between the
human and bacterial complexes. Stanzas for two human
SPT complexes are depicted below. The core complex is
represented by PR:000026144 while PR:000026145 repre-
sents the multimeric functional complex. The complex
composition is formalized using the has_part relation to
the corresponding classes of protein components. The
functional human complex classes have an is_a relation-
ship to the serine C-palmitoyltransferase complex class in
GO (GO:0017059). The complex core has an is_a relation-
ship to GO:0043234 (protein complex) as there is cur-
rently not a more specific complex class in GO.
[Term]
id: PR:000026144
name: serine palmitoyltransferase complex core 1
(human)
def: “A serine palmitoyltransferase complex that is
heterodimeric consisting of one subunit of serine palmi-
toyltransferase 1 and serine palmitoyltransferase 2.
These components are encoded in the genome of
human.” [PRO:CNA]
is_a: GO:0043234 ! protein complex
relationship: has_part PR:000026141 {cardinality =
“1"} ! serine palmitoyltransferase 1 (human)
relationship: has_part PR:000026142 {cardinality =
“1"} ! serine palmitoyltransferase 2 (human)
relationship: only_in_taxon taxon:9606 ! Homo sapiens
[Term]
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name: serine palmitoyltransferase complex A (human)
def: “A serine palmitoyltransferase complex consisting
of an unknown combination of the serine
palmitoyltransferase subunits 1-3. The stoichiometry is
a tetramer composed of the serine
palmitoyltransferase core complexes 1 and/or 2.”
[PMID:17331073, PRO:CNA]
comment: Category = organism-complex. Entities of
this type are disposed to have the enzymatic activity
described by EC:2.3.1.50.
is_a: GO:0017059 ! serine C-palmitoyltransferase
complex
relationship: has_part PR:000026141 {cardinality =
“4"}! serine palmitoyltransferase 1 (human)
relationship: has_part PR:000026142 ! serine palmi-
toyltransferase 2 (human)
relationship: has_part PR:000026143 ! serine palmi-
toyltransferase 3 (human)
relationship: only_in_taxon taxon:9606 ! Homo sapiens
The protein complex stanza for the bacterial SPT
complex (PR:000026169) is shown below. The bacterial
and human complexes differ in composition (Figure 2)
but perform closely similar biochemical functions.
[Term]
id: PR:000026169
name: bacterial serine palmitoyltransferase complex
(Sphingobacterium multivorum)
def: “A homodimeric serine palmitoyltransferase complex
that is composed of bacterial serine palmitoyltransferase
encoded in the genome of Sphingobacterium multivorum.”
[PRO:CNA, PMID:17557831, PMID:19564159]
comment: Category = organism-complex. Entities of
this type are disposed to have the enzymatic activity
described by EC:2.3.1.50.
is_a: GO:0002179 ! homodimeric serine palmitoyl-
transferase complex
relationship: has_part PR:000026168 {cardinality = “2"}
! bacterial serine palmitoyltransferase isoform 1 (Sphin-
gobacterium multivorum)
Figure 2 PRO hierarchy depicting relationship for the human and bacterial SPT complex protein subunits, and for the SPT complexes.
The blue arrows and “I” icons represent is_a relationships among the entities. The protein components have PR ids and the complex concepts
have Gene Ontology (GO) ids.
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terium multivorum
Use Case 3: Mitochondrial Isocitrate Dehydrogenase
Complex; A heterotrimeric complex using different isoforms
for one subunit
There are three types of isocitrate dehydrogenases
(IDHs) in mammals; two IDHs utilize NADP
+ as a
cofactor in the oxidative decarboxylation of isocitrate
and one utilizes NAD
+.T h eN A D
+-dependent IDH is a
mitochondrial protein complex in the citric acid cycle; it
consists of three subunits (alpha, beta, gamma), each of
which is encoded by a single gene. The mouse alpha
subunit gene encodes two different protein isoforms by
alternative splicing. ProComp can distinguish between
complexes that differ in the isoform of one of the con-
stituents. As illustrated below (in bold), the protein
complex stanzas from PRO describe two types of IDH
complexes that differ only in the type of isoform of the
alpha subunit. Both classes of isoform-specific protein
complexes shown below (PR:000026072 and
PR:000026073) are subclasses of the mouse-specific pro-
tein complex class (PR:000026071) which, in turn, is a
subclass of the species-independent complex class
defined in GO (GO:0005962).
[Term]
id: PR:000026071
name: mitochondrial isocitrate dehydrogenase com-
plex (NAD+) (mouse)
definition: A mitochondrial isocitrate dehydrogenase
complex using NAD+ whose components are encoded
in the genome of mouse [PRO:hjd]
is_a:GO:0005962 ! mitochondrial isocitrate dehydro-
genase complex (NAD+)
relationship: has_part PR:000025358 ! isocitrate
dehydrogenase [NAD] subunit alpha, mitochondrial
(mouse)
relationship: has_part PR:000025359 ! isocitrate dehy-
drogenase [NAD] subunit beta, mitochondrial (mouse)
relationship: has_part PR:000025360 ! isocitrate dehy-
drogenase [NAD] subunit gamma, mitochondrial
(mouse)
relationship: only_in_taxon taxon:10090! Mus
musculus
[Term]
id: PR:000026072
name: mitochondrial isocitrate dehydrogenase com-
plex (NAD+) A (mouse)
def: A mitochondrial isocitrate dehydrogenase com-
plex using NAD+ whose components are encoded in
the genome of mouse containing isoform 1 of subunit
alpha” [PRO:hjd]
is_a:PR: 000026071! mitochondrial isocitrate dehydro-
genase complex (NAD+) (mouse)
relationship: has_part PR:000025355 ! isocitrate
dehydrogenase [NAD] subunit alpha, mitochondrial
isoform 1 (mouse)
relationship: has_part PR:000025359 ! isocitrate dehy-
drogenase [NAD] subunit beta, mitochondrial (mouse)
relationship: has_part PR:000025360 ! isocitrate dehy-
drogenase [NAD] subunit gamma, mitochondrial
(mouse)
relationship: only_in_taxon taxon:10090 ! Mus
musculus
[Term]
id: PR:000026073
name:mitochondrial isocitrate dehydrogenase complex
(NAD+) B (mouse)
def: A mitochondrial isocitrate dehydrogenase com-
plex using NAD+ whose components are encoded in
the genome of mouse containing isoform 2 of subunit
alpha” [PRO:hjd]
is_a:PR: 000026071! mitochondrial isocitrate dehydro-
genase complex (NAD+) (mouse)
relationship: has_part PR:000025356 ! isocitrate
dehydrogenase [NAD] subunit alpha, mitochondrial
isoform 2 (mouse)
relationship: has_part PR:000025359 ! isocitrate dehy-
drogenase [NAD] subunit beta, mitochondrial (mouse)
relationship: has_part PR:000025360 ! isocitrate dehy-
drogenase [NAD] subunit gamma, mitochondrial
(mouse)
relationship: only_in_taxon taxon:10090! Mus
musculus
Use Case 4. The Respiratory Chain IV Complex:
Representing uncertainty in complex components
Cytochrome c oxidase, also known as Complex IV (EC
1.9.3.1), is a large transmembrane protein complex
located in the inner mitochondrial membrane. Its func-
tion is sequestration of free radicals, coupled to the
transport of protons across the inner mitochondrial
membrane, which creates the proton gradient used by
mitochondrial ATP synthase during ATP production.
Although the function of Complex IV is well under-
stood, the exact composition of the complex is not cer-
tain due to apparent genetic redundancy. Complex IV is
composed of 13 polypeptides: three encoded in the
mitochondrial genome, and ten encoded in the nuclear
genome [22]. The uncertainty for this complex stems
from the fact that some components of the complex are
known (or predicted) to be encoded by multiple genes
in the nuclear genome. The PRO stanza for Complex IV
shown below illustrates how has_part statements that
refer to “either-or” classes of proteins are used to repre-
sent uncertainty in a compact form with no loss of
information. The union_of statement (highlighted by
bold text in the stanza below) indicates which genes
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union_of tag appears in the appropriate protein compo-
nent stanzas, not in the protein complex stanza. These
tags are shown below (as comments) for illustration
purposes only.
[Term]
id: PR:000026295
name: respiratory chain complex IV (mouse)
def: A mitochondrial respiratory chain complex IV
whose components are encoded in the genome of
mouse. [PRO:CJB, PMID:8638158, PMID:21211513]
is_a: GO:0005751 ! mitochondrial respiratory chain
complex IV
relationship: has_part PR:000025364 {cardinality = “1"}
! cytochrome oxidase subunit 1, mitochondrial (mouse)
relationship: has_part PR:000025366 {cardinality = “1"}
! cytochrome oxidase subunit 2, mitochondrial (mouse)
relationship: has_part PR:000025367 {cardinality = “1"}
! cytochrome oxidase subunit 3, mitochondrial (mouse)
relationship: has_part PR:000026286 complex IV
component 4 (mouse)
! union_of: PR:000025368 ! Cox4i1
! union_of: PR:000025369 ! Cox4i2
relationship: has_part PR:000026294 {cardinality = “1"}
! cytochrome c oxidase subunit 5A, mitochondrial, tran-
sit peptide removed form (mouse)
relationship: has_part PR:000025371 {cardinality = “1"}
! cytochrome c oxidase subunit 5B (mouse)
relationship: has_part PR:000026287 {cardinality = “1"}
! complex IV component 6a (mouse)
! union_of: PR:000025372 ! Cox6a1
! union_of: PR:000025373 ! Cox6a2
relationship: has_part PR:000026288 {cardinality = “1"}
! complex IV component 6b (mouse)
! union_of: PR:000025374 ! Cox6b1
! union_of: PR:000025375 ! Cox6b2
relationship: has_part PR:000025376 {cardinality = “1"}
! cytochrome c oxidase subunit 6C (mouse)
relationship: has_part PR:000026289 {cardinality = “1"}
! complex IV component 7A (mouse)
! union_of: PR:000025377 ! Cox7a1
! union_of: PR:000025378 ! Cox7a2
! union_of: PR:000025379 ! Cox7a2l
relationship: has_part PR:000027496 {cardinality = “1"}
! complex IV component 7B (mouse)
! union of PR:000027491 ! Cox7b
! union of PR:000027489 ! Cox7b2
relationship: has_part PR:000025383 {cardinality = “1"}
! cytochrome c oxidase subunit 7C, mitochondrial
(mouse)
relationship: has_part PR:000026290 {cardinality = “1"}
! complex IV component 8 (mouse)
! union_of: PR:000025380 ! Cox8a
! union_of: PR:000025381 ! Cox8b
! union_of: PR:000025382 ! Cox8c
relationship: only_in_taxon taxon:10090 ! Mus
musculus
While not illustrated in the use cases above, many
PRO complexes have species-specific protein types of
modified isoforms. A few examples are: (i)
PR:000025933 smad2-smad4 protein complex 1
(human), which contains active phosphorylated form of
smad2 (MAD homolog 2), (ii) PR:000026035 myc-max
acetylated complex (human), where both myc (myelocy-
tomatosis oncogene) and max (Max protein) are acety-
lated, and (iii) PR:000027084 IRF3-P:IRF7-P complex
(human), which contains the active phosphorylated
forms of IRF3 (interferon regulatory factor 3) and IRF7
(interferon regulatory factor 7).
Viewing Protein Complex Data in PRO
T h ew e bd i s p l a yo ft h eP r o C o m ps t a n z af o rt h eh u m a n
SPT complex described above in Use Case 2 http://purl.
obolibrary.org/obo/PR_000026144 is shown in Figure 3.
The web page provides human-readable access to
entries in ProComp as well as navigation to detailed
records about the complex subunits and related nodes
in PRO.
Annotating Protein Complexes
The ProComp ontology provides species-specific, acces-
sioned protein complex entities that support robust,
context-specific annotation of protein biology [23].
Comprehensive functional annotation of proteins and
protein complexes is not a mission of the PRO consor-
tium; however, by providing uniquely accessioned pro-
tein complex entities PRO provides a critical and
necessary resource to support unambiguous sharing of
annotations by specialists across multiple biological dis-
ciplines. To support data exchange and integration by
model organism and pathway database groups that are
annotating protein complexes, biological annotations of
proteins and protein complexes can be represented in
Protein Annotation Files (PAF). PAFs are modeled on
the Gene Annotation Files (GAFs) generated for GO
annotations http://www.geneontology.org/GO.format.
gaf-1_0.shtml. The PAF format consists of a standard
header and 20 tab-delimited columns (11 required; 9
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ontology/pro_obo/PAF_guidelines.pdf).
Figure 4 illustrates how a PAF is used to provide bio-
logical context for proteins and protein complexes for
the MCC complex described in Use Case 1 above. 3-
Methylcrotonylglycinuria is an inborn error of leucine
catabolism caused by deficiency of 3-methylcrotonyl-
CoA carboxylase activity (MCC; EC 6.4.1.4). Knowledge
that mutations in human genes that encode the protein
components of the MCC complex: MCCC1 (subunit
alpha) and MCCC2 (subunit beta), cause methylcroto-
nylglycinuria type I (OMIM #210200) and methylcroto-
nylglycinuria type II (OMIM #210210), respectively, are
represented in the PAF file (ftp://ftp.pir.georgetown.edu/
databases/ontology/pro_obo/, and Figure 4). As shown,
each variant of MCCC1 and MCCC2 has its own PRO
ID and annotation. Annotations of variants may include
sequence-related attributes (annotated with Sequence
Ontology [24] terms; SO), relation to disease (annotated
with MIM [25]), and/or functional information (anno-
tated with GO). In this particular case the SO annota-
tion provides important information regarding the
sequence nature of the variant. Two of the variants in
Figure 4 are generated because of missense mutations
that, while within exons, alter RNA splicing either by
removing a splice site (MCCAD532H, PR:000026111),
or by activating a cryptic splice donor site (MCCB
I437V, PR:000026121) [26]. In addition, the PAF makes
i tp o s s i b l et oi n d i c a t es e q u e n c ev a r i a n t sw h i c ha l t e ra
biological process or function, as in MCCA L437P.
Figure 4 Example of a Protein Annotation File (PAF) showing biological annotations for MCCC1 (MCCA) and MCCC2 (MCCB) human
variants. Only columns with information are shown and short names of the variants are used. This PAF file is available via the PRO ftp site: ftp://
ftp.pir.georgetown.edu/databases/ontology/pro_obo/.
Figure 3 Screenshot of the PRO entry for human serine palmitoyltransferase complex core 1 (SPT) as displayed on the PRO web site.
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The uniquely identified, species-specific protein complex
classes in ProComp serve as a framework for formal
representation of these biological entities and their bio-
logical contexts. For example, Na+-K+-ATPases, or
“sodium pumps” create both an electrical and chemical
gradient across the plasma membrane. Sodium pumps
are usually tetramers consisting of two catalytic alpha,
and two membrane-bound beta subunits. However, in
high osmolarity environments such as kidney epithe-
lium, a third (gamma) subunit is required for their
proper functioning [27,28]. In mammals, each of the
subunits is encoded by members of a multi-gene family
and different subunit combinations likely provide tissue
and developmental specificities of the entities exercising
sodium pump functions. As illustrated in this manu-
script, the design of the ProComp ontology supports the
representation of the compositional complexity of pro-
tein complexes and, combined with information from
manually-curated databases such as Reactome and Mou-
seCyc, facilitates robust annotation of rich biological
contexts as well. Future directions for data acquisition
and curation within the ProComp project include work-
ing with a wide range of community bio-curation
resources and investigators to create protein complex
records that support curation of experimental annota-
tions. We are developing software to convert PRO-rele-
vant information from database resources into an
ontological format. We are also extending an existing
web-based data entry tool http://pir.georgetown.edu/cgi-
bin/pro/race_pro that will support direct submission of
protein complexes to PRO. The representation of pro-
tein complexes classes in PRO will be revisited fre-
quently as additional information and evidence about
their composition and stochiometry is identified in the
scientific literature by PRO curators.
Improvements in the PRO ontology and annotation
have come to light by our work on the use cases
described in this manuscript. We outline a number of
known issues that serve as the basis for future work.
First, while the assertions in stanzas within PRO are
intended to be backed by evidence, the distinction
between experimental and inferential evidence (both
legitimate) is not yet captured clearly. This is especially
true in cases where the evidence for composition and
stochiometry for protein complexes is derived from
orthologous proteins and complexes in other organisms.
Usefully recording such information, as we recognize is
important, was hampered by deficits in our curation
tools that made it impossible to record evidence for
individual relations or, more specifically, cardinality. We
are working with the Ontology for Biomedical Investiga-
tions (OBI; http://obi-ontology.org/) group on the devel-
opment and application of an evidence code ontology to
describe the evidence used to support protein complex
assertions in ProComp, and with developers of the cura-
tion tools to enable capturing such evidence with appro-
priate granularity. Second, our current work records
only protein monomer components of complexes facili-
tated by an interface that makes selection of the mono-
mers and their identifiers manageable. However, as we
note, protein complexes (such as Complex IV in Use
Case 4) are known to have lipid, heme, and other co-
factors as components. Extensions to our curation tools
will be developed in order to select and include such
components, identifiers for which are provided by, e.g.,
the Chemical Entities of Biological Interest (CheBI)
ontology [29]. Third, there is further work to be done
on the relations that connect protein complex and gene
product mutation variants to disease. We have used
has_agent and is_agent_in relations in our annotations
to connect, provisionally, proteins with representation of
sequence variation from the Sequence Ontology. How-
ever this does not agree with the formal definition in
which these relations connect processes with their parti-
cipants [30]. We plan to work with developers of the
Relation Ontology to define appropriate relations.
Fourth, we will work to improve the axioms we use to
better enable use of reasoners to check consistency and
facilitate advanced query. For example, ProComp cur-
rently uses has_part to relate a protein complex to its
components and uses cardinality restriction to represent
stoichiometry. However, because has_part is a transitive
relation, the ontology falls outside OWL2-DL making it
not possible to use standard reasoners. Thus, we are
evaluating the possibility of replacing has_part with a
new relation that is a non-transitive sub-property of the
has_part relation. Finally, we will implement closure
axioms that would more clearly define the number and
kind of complex components. For example, our repre-
sentation of Complex IV allows that there might be
additional protein components because of the open
world assumption. A closure axiom would assert that
exactly 13 of the components of this complex are pro-
teins, while still allowing that there might be other
kinds of components.
Availability and requirements
The Protein Ontology resource can be accessed on-line
http://pir.georgetown.edu/pro/. Users can search PRO
using accession IDs (e.g. PRO, UniProtKB, GO) or text
(e.g., term name, definitions, synonyms). Searches can
be restricted to specific modified forms (phosphorylated,
etc.), database, or membership in a complex. PRO
entries can also be accessed via hypertext links on gene
detail pages in the Mouse Genome Informatics (MGI)
database and from MouseCyc, Reactome, and EcoCyc.
PRO (Release 20) contains 168 complexes drawn from
Bult et al. BMC Bioinformatics 2011, 12:371
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Page 9 of 11Reactome (human), MouseCyc (mouse), EcoCyc (E. coli)
and direct submissions from collaborating research
groups. OBO Edit, an open source ontology editing tool
http://oboedit.org/[31], can be used to view all of the
relationships represented in protein complex stanzas
from ProComp.
Existing conversion tools allow for OBO-formatted
ontologies to be converted into Web ontology language
(OWL) [32,33]. The PRO ontology is available in a
number of formats, including OWL (latest version
always at http://purl.obolibrary.org/obo/pr.owl).
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